HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease.

Abstract
Background: It was previously shown that a bodyweight reduction among patients with nonalcoholic fatty liver (NAFLD) was connected to the lower concentration of arachidonic and linoleic acid derivatives in their blood. We hypothesized that the concentration of these lipids was correlated with the extent of their body mass reduction and, thus, liver steatosis. Methods: We analyzed 68 individuals who completed the dietary intervention. Patients were divided into two groups depending on their body mass reduction (more or less than 7%). Before and after the dietary intervention, all patients had the following measurements recorded: body mass, waist circumference, stage of steatosis, fatty liver index, liver enzymes, lipid parameters, insulin and glucose. Concentrations of lipoxins A4 (LTX A4), hydroxyeicosatetraenoic fatty acids (5(S)-HETE, 12(S)-HETE and 16(S)-HETE), hydroxyoctadecaenoic acids (9(S)-HODE and 13(S)-HODE) and 5-oxo-eicosatetraenoic acid (5-oxo-ETE) were measured in serum samples collected before and after the dietetic intervention using high-performance liquid chromatography (HPLC). Results: Patients who reduced their body mass by more than 7% revealed a significant improvement in their steatosis stage, waist circumference, fatty liver index, triglycerides and cholesterol. Conclusion: A reduction in body mass by more than 7% but not by less than 7% revealed a significant improvement in steatosis stage; waist circumference; fatty liver index; and levels of triglycerides, cholesterol, 5-oxo-ETE and LTXA-4.
AuthorsMarcin Banaszczak, Dominika Maciejewska, Arleta Drozd, Karina Ryterska, Dominika Jamioł Milc, Joanna Raszeja-Wyszomirska, Ewa Wunsch, Pedro González-Muniesa, Ewa Stachowska
JournalMedicina (Kaunas, Lithuania) (Medicina (Kaunas)) Vol. 56 Issue 2 (Feb 03 2020) ISSN: 1648-9144 [Electronic] Switzerland
PMID32028646 (Publication Type: Journal Article)
Chemical References
  • 5-oxo-eicosatetraenoic acid
  • Arachidonic Acids
  • Biomarkers
  • Fatty Acids, Unsaturated
  • Hydroxyeicosatetraenoic Acids
  • Lipoxins
  • Triglycerides
  • hydroxyoctadecadienoic acid
  • Cholesterol
  • Arachidonate 5-Lipoxygenase
Topics
  • Arachidonate 5-Lipoxygenase
  • Arachidonic Acids (blood)
  • Biomarkers (blood)
  • Body Mass Index
  • Cholesterol (blood)
  • Diet, Reducing
  • Energy Intake
  • Fatty Acids, Unsaturated (blood)
  • Humans
  • Hydroxyeicosatetraenoic Acids (blood)
  • Lipoxins (blood)
  • Liver (enzymology)
  • Non-alcoholic Fatty Liver Disease (blood, diet therapy)
  • Statistics, Nonparametric
  • Treatment Outcome
  • Triglycerides (blood)
  • Waist Circumference
  • Weight Loss

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: